Midterm elections provide a surprising lift for drug stocks, with one analyst calling outcome a ‘best-case scenario’
November 07, 2018 at 10:03 AM EST
Pharmaceutical prices are one of the few potentially bipartisan issues for this new Congress. But that didn’t stop policy experts and analysts from calling the latest results a win.
